Close Menu

NEW YORK – Euroimmun will sell Oncgnostics'cervical cancer test in parts of Europe under an agreement announced on Thursday.

Euroimmun, a PerkinElmer subsidiary, will sell the GynTect test in Portugal, Italy, Turkey, and Poland. Financial and other terms of the deal were not disclosed.

Germany-based Oncgnostics added that it expects the test to be approved by regulators in Canada and to be sold there by the end of the year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.